Clinical Trial Update: Got Doxy- 'Flipping the Script' on STI PEP [Phase 4]

View source ↗

Summary

Emory University is recruiting for a Phase 4 trial evaluating doxycycline post-exposure prophylaxis for sexually transmitted infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sexually Transmitted Infections

Drugs mentioned

• Doxycycline (Doxycycline)

Snippet

Sponsor: Emory University | Conditions: Sexually Transmitted Infections (STI) | Phase 4 | Status: RECRUITING